nodes	percent_of_prediction	percent_of_DWPC	metapath
Darifenacin—CHRM3—ureter—colon cancer	0.0904	0.433	CbGeAlD
Darifenacin—CHRM3—muscle of abdomen—colon cancer	0.0651	0.312	CbGeAlD
Darifenacin—Obstructive airways disorder—Methotrexate—colon cancer	0.0215	0.0275	CcSEcCtD
Darifenacin—Depressed mood—Capecitabine—colon cancer	0.0147	0.0188	CcSEcCtD
Darifenacin—CHRM5—epithelium—colon cancer	0.0139	0.0663	CbGeAlD
Darifenacin—Accidental injury—Irinotecan—colon cancer	0.0111	0.0142	CcSEcCtD
Darifenacin—Cough increased—Irinotecan—colon cancer	0.0107	0.0137	CcSEcCtD
Darifenacin—Ulcerative stomatitis—Methotrexate—colon cancer	0.0106	0.0135	CcSEcCtD
Darifenacin—Mouth ulceration—Vincristine—colon cancer	0.0091	0.0116	CcSEcCtD
Darifenacin—Injury—Irinotecan—colon cancer	0.00774	0.0099	CcSEcCtD
Darifenacin—Visual disturbance—Irinotecan—colon cancer	0.00751	0.0096	CcSEcCtD
Darifenacin—CHRM3—smooth muscle tissue—colon cancer	0.00747	0.0357	CbGeAlD
Darifenacin—Cerebrovascular accident—Irinotecan—colon cancer	0.00726	0.00928	CcSEcCtD
Darifenacin—CHRM3—renal system—colon cancer	0.00719	0.0344	CbGeAlD
Darifenacin—Urinary retention—Vincristine—colon cancer	0.00695	0.00888	CcSEcCtD
Darifenacin—Aspartate aminotransferase increased—Vincristine—colon cancer	0.00658	0.00841	CcSEcCtD
Darifenacin—Aspartate aminotransferase increased—Irinotecan—colon cancer	0.00641	0.00819	CcSEcCtD
Darifenacin—Dry skin—Fluorouracil—colon cancer	0.00625	0.00799	CcSEcCtD
Darifenacin—Dry eye—Capecitabine—colon cancer	0.00606	0.00775	CcSEcCtD
Darifenacin—Mouth ulceration—Capecitabine—colon cancer	0.00593	0.00758	CcSEcCtD
Darifenacin—CHRM3—digestive system—colon cancer	0.0059	0.0282	CbGeAlD
Darifenacin—Erectile dysfunction—Vincristine—colon cancer	0.00582	0.00744	CcSEcCtD
Darifenacin—Abnormal vision—Capecitabine—colon cancer	0.00572	0.00732	CcSEcCtD
Darifenacin—Mental disability—Capecitabine—colon cancer	0.00569	0.00728	CcSEcCtD
Darifenacin—Stomatitis—Vincristine—colon cancer	0.00549	0.00702	CcSEcCtD
Darifenacin—Sweating—Vincristine—colon cancer	0.0054	0.0069	CcSEcCtD
Darifenacin—Stomatitis—Irinotecan—colon cancer	0.00535	0.00683	CcSEcCtD
Darifenacin—Sweating—Irinotecan—colon cancer	0.00526	0.00672	CcSEcCtD
Darifenacin—Infestation NOS—Fluorouracil—colon cancer	0.00525	0.00672	CcSEcCtD
Darifenacin—Infestation—Fluorouracil—colon cancer	0.00525	0.00672	CcSEcCtD
Darifenacin—Stomatitis—Fluorouracil—colon cancer	0.00512	0.00655	CcSEcCtD
Darifenacin—Urinary tract infection—Fluorouracil—colon cancer	0.00511	0.00653	CcSEcCtD
Darifenacin—Hallucination—Vincristine—colon cancer	0.00503	0.00643	CcSEcCtD
Darifenacin—Urinary tract disorder—Vincristine—colon cancer	0.00499	0.00638	CcSEcCtD
Darifenacin—Urethral disorder—Vincristine—colon cancer	0.00496	0.00634	CcSEcCtD
Darifenacin—Rhinitis—Irinotecan—colon cancer	0.00494	0.00631	CcSEcCtD
Darifenacin—Sinusitis—Fluorouracil—colon cancer	0.00493	0.0063	CcSEcCtD
Darifenacin—Vaginal inflammation—Methotrexate—colon cancer	0.00489	0.00625	CcSEcCtD
Darifenacin—Cerebrovascular accident—Capecitabine—colon cancer	0.00486	0.00621	CcSEcCtD
Darifenacin—Visual impairment—Irinotecan—colon cancer	0.00475	0.00607	CcSEcCtD
Darifenacin—Rhinitis—Fluorouracil—colon cancer	0.00473	0.00604	CcSEcCtD
Darifenacin—Pharyngitis—Fluorouracil—colon cancer	0.00468	0.00598	CcSEcCtD
Darifenacin—Vaginal infection—Methotrexate—colon cancer	0.00461	0.0059	CcSEcCtD
Darifenacin—Face oedema—Capecitabine—colon cancer	0.0046	0.00588	CcSEcCtD
Darifenacin—Angiopathy—Vincristine—colon cancer	0.00459	0.00586	CcSEcCtD
Darifenacin—Mediastinal disorder—Vincristine—colon cancer	0.00456	0.00582	CcSEcCtD
Darifenacin—Urinary retention—Capecitabine—colon cancer	0.00453	0.00579	CcSEcCtD
Darifenacin—Angiopathy—Irinotecan—colon cancer	0.00447	0.00571	CcSEcCtD
Darifenacin—Mediastinal disorder—Irinotecan—colon cancer	0.00444	0.00567	CcSEcCtD
Darifenacin—Mental disorder—Vincristine—colon cancer	0.00443	0.00566	CcSEcCtD
Darifenacin—Bladder pain—Methotrexate—colon cancer	0.00442	0.00565	CcSEcCtD
Darifenacin—Mouth ulceration—Methotrexate—colon cancer	0.00442	0.00565	CcSEcCtD
Darifenacin—Dry skin—Capecitabine—colon cancer	0.00437	0.00558	CcSEcCtD
Darifenacin—Breast disorder—Capecitabine—colon cancer	0.0043	0.0055	CcSEcCtD
Darifenacin—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.00429	0.00548	CcSEcCtD
Darifenacin—Back pain—Vincristine—colon cancer	0.00426	0.00544	CcSEcCtD
Darifenacin—Flatulence—Irinotecan—colon cancer	0.00422	0.0054	CcSEcCtD
Darifenacin—Alanine aminotransferase increased—Capecitabine—colon cancer	0.0042	0.00537	CcSEcCtD
Darifenacin—Back pain—Irinotecan—colon cancer	0.00415	0.0053	CcSEcCtD
Darifenacin—Influenza—Capecitabine—colon cancer	0.00412	0.00526	CcSEcCtD
Darifenacin—Bronchitis—Capecitabine—colon cancer	0.00396	0.00506	CcSEcCtD
Darifenacin—CYP3A4—renal system—colon cancer	0.00395	0.0189	CbGeAlD
Darifenacin—CYP2D6—renal system—colon cancer	0.00389	0.0186	CbGeAlD
Darifenacin—Vision blurred—Fluorouracil—colon cancer	0.00387	0.00495	CcSEcCtD
Darifenacin—Syncope—Irinotecan—colon cancer	0.00384	0.00491	CcSEcCtD
Darifenacin—Hypertension—Vincristine—colon cancer	0.0038	0.00486	CcSEcCtD
Darifenacin—Loss of consciousness—Irinotecan—colon cancer	0.00377	0.00482	CcSEcCtD
Darifenacin—Weight increased—Capecitabine—colon cancer	0.00375	0.00479	CcSEcCtD
Darifenacin—Visual disturbance—Methotrexate—colon cancer	0.00374	0.00478	CcSEcCtD
Darifenacin—Cough—Irinotecan—colon cancer	0.00374	0.00478	CcSEcCtD
Darifenacin—Hypertension—Irinotecan—colon cancer	0.0037	0.00473	CcSEcCtD
Darifenacin—Infestation NOS—Capecitabine—colon cancer	0.00367	0.00469	CcSEcCtD
Darifenacin—Infestation—Capecitabine—colon cancer	0.00367	0.00469	CcSEcCtD
Darifenacin—Cerebrovascular accident—Methotrexate—colon cancer	0.00362	0.00463	CcSEcCtD
Darifenacin—Anaphylactic shock—Vincristine—colon cancer	0.00359	0.00459	CcSEcCtD
Darifenacin—Oedema—Vincristine—colon cancer	0.00359	0.00459	CcSEcCtD
Darifenacin—Stomatitis—Capecitabine—colon cancer	0.00358	0.00457	CcSEcCtD
Darifenacin—Infection—Vincristine—colon cancer	0.00357	0.00456	CcSEcCtD
Darifenacin—Urinary tract infection—Capecitabine—colon cancer	0.00357	0.00456	CcSEcCtD
Darifenacin—Confusional state—Irinotecan—colon cancer	0.00353	0.00451	CcSEcCtD
Darifenacin—Nervous system disorder—Vincristine—colon cancer	0.00352	0.0045	CcSEcCtD
Darifenacin—Anaphylactic shock—Irinotecan—colon cancer	0.0035	0.00447	CcSEcCtD
Darifenacin—Oedema—Irinotecan—colon cancer	0.0035	0.00447	CcSEcCtD
Darifenacin—Infection—Irinotecan—colon cancer	0.00348	0.00444	CcSEcCtD
Darifenacin—Hyperhidrosis—Vincristine—colon cancer	0.00347	0.00444	CcSEcCtD
Darifenacin—Shock—Irinotecan—colon cancer	0.00344	0.0044	CcSEcCtD
Darifenacin—Nervous system disorder—Irinotecan—colon cancer	0.00343	0.00439	CcSEcCtD
Darifenacin—Hyperhidrosis—Irinotecan—colon cancer	0.00338	0.00432	CcSEcCtD
Darifenacin—Confusional state—Fluorouracil—colon cancer	0.00338	0.00432	CcSEcCtD
Darifenacin—Oedema—Fluorouracil—colon cancer	0.00335	0.00428	CcSEcCtD
Darifenacin—Anaphylactic shock—Fluorouracil—colon cancer	0.00335	0.00428	CcSEcCtD
Darifenacin—Infection—Fluorouracil—colon cancer	0.00333	0.00425	CcSEcCtD
Darifenacin—Rhinitis—Capecitabine—colon cancer	0.0033	0.00422	CcSEcCtD
Darifenacin—Nervous system disorder—Fluorouracil—colon cancer	0.00329	0.0042	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Vincristine—colon cancer	0.00327	0.00418	CcSEcCtD
Darifenacin—Pharyngitis—Capecitabine—colon cancer	0.00327	0.00418	CcSEcCtD
Darifenacin—Tachycardia—Fluorouracil—colon cancer	0.00327	0.00418	CcSEcCtD
Darifenacin—Urinary tract disorder—Capecitabine—colon cancer	0.00325	0.00416	CcSEcCtD
Darifenacin—Insomnia—Vincristine—colon cancer	0.00325	0.00415	CcSEcCtD
Darifenacin—Oedema peripheral—Capecitabine—colon cancer	0.00325	0.00415	CcSEcCtD
Darifenacin—CYP3A4—digestive system—colon cancer	0.00324	0.0155	CbGeAlD
Darifenacin—Urethral disorder—Capecitabine—colon cancer	0.00323	0.00413	CcSEcCtD
Darifenacin—Breast disorder—Methotrexate—colon cancer	0.0032	0.0041	CcSEcCtD
Darifenacin—CYP2D6—digestive system—colon cancer	0.00319	0.0153	CbGeAlD
Darifenacin—Visual impairment—Capecitabine—colon cancer	0.00318	0.00406	CcSEcCtD
Darifenacin—Insomnia—Irinotecan—colon cancer	0.00316	0.00404	CcSEcCtD
Darifenacin—Dyspnoea—Irinotecan—colon cancer	0.00312	0.00399	CcSEcCtD
Darifenacin—Erythema multiforme—Capecitabine—colon cancer	0.00312	0.00398	CcSEcCtD
Darifenacin—Somnolence—Irinotecan—colon cancer	0.00311	0.00398	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Vincristine—colon cancer	0.0031	0.00396	CcSEcCtD
Darifenacin—Eye disorder—Capecitabine—colon cancer	0.00308	0.00394	CcSEcCtD
Darifenacin—Dyspepsia—Irinotecan—colon cancer	0.00308	0.00394	CcSEcCtD
Darifenacin—Pain—Vincristine—colon cancer	0.00307	0.00393	CcSEcCtD
Darifenacin—Constipation—Vincristine—colon cancer	0.00307	0.00393	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00305	0.0039	CcSEcCtD
Darifenacin—Insomnia—Fluorouracil—colon cancer	0.00303	0.00387	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Irinotecan—colon cancer	0.00302	0.00386	CcSEcCtD
Darifenacin—Constipation—Irinotecan—colon cancer	0.00299	0.00382	CcSEcCtD
Darifenacin—Pain—Irinotecan—colon cancer	0.00299	0.00382	CcSEcCtD
Darifenacin—Angiopathy—Capecitabine—colon cancer	0.00299	0.00382	CcSEcCtD
Darifenacin—Dyspnoea—Fluorouracil—colon cancer	0.00299	0.00382	CcSEcCtD
Darifenacin—Somnolence—Fluorouracil—colon cancer	0.00298	0.00381	CcSEcCtD
Darifenacin—Mediastinal disorder—Capecitabine—colon cancer	0.00297	0.0038	CcSEcCtD
Darifenacin—Dyspepsia—Fluorouracil—colon cancer	0.00295	0.00377	CcSEcCtD
Darifenacin—Gastrointestinal pain—Vincristine—colon cancer	0.00294	0.00375	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00289	0.0037	CcSEcCtD
Darifenacin—Mental disorder—Capecitabine—colon cancer	0.00289	0.00369	CcSEcCtD
Darifenacin—Feeling abnormal—Irinotecan—colon cancer	0.00288	0.00369	CcSEcCtD
Darifenacin—Pain—Fluorouracil—colon cancer	0.00287	0.00366	CcSEcCtD
Darifenacin—Gastrointestinal pain—Irinotecan—colon cancer	0.00286	0.00366	CcSEcCtD
Darifenacin—Abdominal pain—Vincristine—colon cancer	0.00284	0.00363	CcSEcCtD
Darifenacin—Flatulence—Capecitabine—colon cancer	0.00283	0.00361	CcSEcCtD
Darifenacin—Erectile dysfunction—Methotrexate—colon cancer	0.00282	0.00361	CcSEcCtD
Darifenacin—Dysgeusia—Capecitabine—colon cancer	0.00281	0.00359	CcSEcCtD
Darifenacin—Back pain—Capecitabine—colon cancer	0.00278	0.00355	CcSEcCtD
Darifenacin—Abdominal pain—Irinotecan—colon cancer	0.00277	0.00354	CcSEcCtD
Darifenacin—Feeling abnormal—Fluorouracil—colon cancer	0.00276	0.00353	CcSEcCtD
Darifenacin—Infestation NOS—Methotrexate—colon cancer	0.00273	0.00349	CcSEcCtD
Darifenacin—Infestation—Methotrexate—colon cancer	0.00273	0.00349	CcSEcCtD
Darifenacin—Vision blurred—Capecitabine—colon cancer	0.0027	0.00346	CcSEcCtD
Darifenacin—Stomatitis—Methotrexate—colon cancer	0.00266	0.00341	CcSEcCtD
Darifenacin—Hypersensitivity—Vincristine—colon cancer	0.00265	0.00338	CcSEcCtD
Darifenacin—Sweating—Methotrexate—colon cancer	0.00262	0.00335	CcSEcCtD
Darifenacin—Hypersensitivity—Irinotecan—colon cancer	0.00258	0.00329	CcSEcCtD
Darifenacin—Asthenia—Vincristine—colon cancer	0.00258	0.00329	CcSEcCtD
Darifenacin—Syncope—Capecitabine—colon cancer	0.00257	0.00329	CcSEcCtD
Darifenacin—Palpitations—Capecitabine—colon cancer	0.00254	0.00324	CcSEcCtD
Darifenacin—Loss of consciousness—Capecitabine—colon cancer	0.00252	0.00322	CcSEcCtD
Darifenacin—Asthenia—Irinotecan—colon cancer	0.00251	0.00321	CcSEcCtD
Darifenacin—Cough—Capecitabine—colon cancer	0.0025	0.0032	CcSEcCtD
Darifenacin—Fexofenadine—ABCB1—colon cancer	0.00248	0.284	CrCbGaD
Darifenacin—Hypertension—Capecitabine—colon cancer	0.00248	0.00317	CcSEcCtD
Darifenacin—Hypersensitivity—Fluorouracil—colon cancer	0.00247	0.00316	CcSEcCtD
Darifenacin—Diarrhoea—Vincristine—colon cancer	0.00246	0.00314	CcSEcCtD
Darifenacin—Arthralgia—Capecitabine—colon cancer	0.00244	0.00312	CcSEcCtD
Darifenacin—Pharyngitis—Methotrexate—colon cancer	0.00243	0.00311	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.00243	0.0031	CcSEcCtD
Darifenacin—Urinary tract disorder—Methotrexate—colon cancer	0.00242	0.0031	CcSEcCtD
Darifenacin—CYP3A4—liver—colon cancer	0.00241	0.0116	CbGeAlD
Darifenacin—Urethral disorder—Methotrexate—colon cancer	0.0024	0.00307	CcSEcCtD
Darifenacin—Diarrhoea—Irinotecan—colon cancer	0.00239	0.00306	CcSEcCtD
Darifenacin—Dry mouth—Capecitabine—colon cancer	0.00239	0.00305	CcSEcCtD
Darifenacin—CYP2D6—liver—colon cancer	0.00238	0.0114	CbGeAlD
Darifenacin—Dizziness—Vincristine—colon cancer	0.00238	0.00304	CcSEcCtD
Darifenacin—Pruritus—Fluorouracil—colon cancer	0.00237	0.00303	CcSEcCtD
Darifenacin—Visual impairment—Methotrexate—colon cancer	0.00236	0.00302	CcSEcCtD
Darifenacin—Confusional state—Capecitabine—colon cancer	0.00236	0.00302	CcSEcCtD
Darifenacin—Oedema—Capecitabine—colon cancer	0.00234	0.00299	CcSEcCtD
Darifenacin—Infection—Capecitabine—colon cancer	0.00233	0.00297	CcSEcCtD
Darifenacin—Erythema multiforme—Methotrexate—colon cancer	0.00232	0.00297	CcSEcCtD
Darifenacin—Dizziness—Irinotecan—colon cancer	0.00231	0.00296	CcSEcCtD
Darifenacin—Shock—Capecitabine—colon cancer	0.0023	0.00294	CcSEcCtD
Darifenacin—Nervous system disorder—Capecitabine—colon cancer	0.0023	0.00294	CcSEcCtD
Darifenacin—Eye disorder—Methotrexate—colon cancer	0.00229	0.00293	CcSEcCtD
Darifenacin—Diarrhoea—Fluorouracil—colon cancer	0.00229	0.00293	CcSEcCtD
Darifenacin—Tachycardia—Capecitabine—colon cancer	0.00229	0.00292	CcSEcCtD
Darifenacin—Vomiting—Vincristine—colon cancer	0.00228	0.00292	CcSEcCtD
Darifenacin—Skin disorder—Capecitabine—colon cancer	0.00227	0.00291	CcSEcCtD
Darifenacin—Rash—Vincristine—colon cancer	0.00226	0.0029	CcSEcCtD
Darifenacin—Hyperhidrosis—Capecitabine—colon cancer	0.00226	0.00289	CcSEcCtD
Darifenacin—Dermatitis—Vincristine—colon cancer	0.00226	0.00289	CcSEcCtD
Darifenacin—Headache—Vincristine—colon cancer	0.00225	0.00288	CcSEcCtD
Darifenacin—Angiopathy—Methotrexate—colon cancer	0.00223	0.00285	CcSEcCtD
Darifenacin—Vomiting—Irinotecan—colon cancer	0.00222	0.00284	CcSEcCtD
Darifenacin—Dizziness—Fluorouracil—colon cancer	0.00222	0.00283	CcSEcCtD
Darifenacin—Mediastinal disorder—Methotrexate—colon cancer	0.00221	0.00283	CcSEcCtD
Darifenacin—Rash—Irinotecan—colon cancer	0.00221	0.00282	CcSEcCtD
Darifenacin—Dermatitis—Irinotecan—colon cancer	0.0022	0.00282	CcSEcCtD
Darifenacin—Headache—Irinotecan—colon cancer	0.00219	0.0028	CcSEcCtD
Darifenacin—Mental disorder—Methotrexate—colon cancer	0.00215	0.00275	CcSEcCtD
Darifenacin—Nausea—Vincristine—colon cancer	0.00213	0.00273	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00213	0.00273	CcSEcCtD
Darifenacin—Vomiting—Fluorouracil—colon cancer	0.00213	0.00272	CcSEcCtD
Darifenacin—Insomnia—Capecitabine—colon cancer	0.00212	0.00271	CcSEcCtD
Darifenacin—Rash—Fluorouracil—colon cancer	0.00211	0.0027	CcSEcCtD
Darifenacin—Dermatitis—Fluorouracil—colon cancer	0.00211	0.0027	CcSEcCtD
Darifenacin—Headache—Fluorouracil—colon cancer	0.0021	0.00268	CcSEcCtD
Darifenacin—Dysgeusia—Methotrexate—colon cancer	0.00209	0.00267	CcSEcCtD
Darifenacin—Dyspnoea—Capecitabine—colon cancer	0.00209	0.00267	CcSEcCtD
Darifenacin—Nausea—Irinotecan—colon cancer	0.00208	0.00266	CcSEcCtD
Darifenacin—Back pain—Methotrexate—colon cancer	0.00207	0.00264	CcSEcCtD
Darifenacin—Dyspepsia—Capecitabine—colon cancer	0.00206	0.00263	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Capecitabine—colon cancer	0.00202	0.00258	CcSEcCtD
Darifenacin—Vision blurred—Methotrexate—colon cancer	0.00201	0.00257	CcSEcCtD
Darifenacin—Pain—Capecitabine—colon cancer	0.002	0.00256	CcSEcCtD
Darifenacin—Constipation—Capecitabine—colon cancer	0.002	0.00256	CcSEcCtD
Darifenacin—Nausea—Fluorouracil—colon cancer	0.00199	0.00254	CcSEcCtD
Darifenacin—Feeling abnormal—Capecitabine—colon cancer	0.00193	0.00247	CcSEcCtD
Darifenacin—Clotrimazole—ABCB1—colon cancer	0.00192	0.219	CrCbGaD
Darifenacin—Gastrointestinal pain—Capecitabine—colon cancer	0.00191	0.00245	CcSEcCtD
Darifenacin—Cough—Methotrexate—colon cancer	0.00186	0.00238	CcSEcCtD
Darifenacin—Abdominal pain—Capecitabine—colon cancer	0.00185	0.00237	CcSEcCtD
Darifenacin—Arthralgia—Methotrexate—colon cancer	0.00182	0.00232	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.00181	0.00231	CcSEcCtD
Darifenacin—Confusional state—Methotrexate—colon cancer	0.00176	0.00225	CcSEcCtD
Darifenacin—Anaphylactic shock—Methotrexate—colon cancer	0.00174	0.00223	CcSEcCtD
Darifenacin—Infection—Methotrexate—colon cancer	0.00173	0.00221	CcSEcCtD
Darifenacin—Hypersensitivity—Capecitabine—colon cancer	0.00173	0.00221	CcSEcCtD
Darifenacin—Nervous system disorder—Methotrexate—colon cancer	0.00171	0.00218	CcSEcCtD
Darifenacin—Skin disorder—Methotrexate—colon cancer	0.00169	0.00216	CcSEcCtD
Darifenacin—Hyperhidrosis—Methotrexate—colon cancer	0.00168	0.00215	CcSEcCtD
Darifenacin—Asthenia—Capecitabine—colon cancer	0.00168	0.00215	CcSEcCtD
Darifenacin—Pruritus—Capecitabine—colon cancer	0.00166	0.00212	CcSEcCtD
Darifenacin—Fentanyl—ABCB1—colon cancer	0.00164	0.188	CrCbGaD
Darifenacin—Diarrhoea—Capecitabine—colon cancer	0.0016	0.00205	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Methotrexate—colon cancer	0.00159	0.00203	CcSEcCtD
Darifenacin—Loperamide—ABCB1—colon cancer	0.00158	0.181	CrCbGaD
Darifenacin—Insomnia—Methotrexate—colon cancer	0.00158	0.00202	CcSEcCtD
Darifenacin—Dyspnoea—Methotrexate—colon cancer	0.00155	0.00199	CcSEcCtD
Darifenacin—Somnolence—Methotrexate—colon cancer	0.00155	0.00198	CcSEcCtD
Darifenacin—Dizziness—Capecitabine—colon cancer	0.00155	0.00198	CcSEcCtD
Darifenacin—Dyspepsia—Methotrexate—colon cancer	0.00153	0.00196	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Methotrexate—colon cancer	0.0015	0.00192	CcSEcCtD
Darifenacin—Pain—Methotrexate—colon cancer	0.00149	0.00191	CcSEcCtD
Darifenacin—Vomiting—Capecitabine—colon cancer	0.00149	0.0019	CcSEcCtD
Darifenacin—Rash—Capecitabine—colon cancer	0.00148	0.00189	CcSEcCtD
Darifenacin—Dermatitis—Capecitabine—colon cancer	0.00147	0.00189	CcSEcCtD
Darifenacin—Headache—Capecitabine—colon cancer	0.00147	0.00187	CcSEcCtD
Darifenacin—Feeling abnormal—Methotrexate—colon cancer	0.00144	0.00184	CcSEcCtD
Darifenacin—Gastrointestinal pain—Methotrexate—colon cancer	0.00143	0.00182	CcSEcCtD
Darifenacin—Nausea—Capecitabine—colon cancer	0.00139	0.00178	CcSEcCtD
Darifenacin—Abdominal pain—Methotrexate—colon cancer	0.00138	0.00176	CcSEcCtD
Darifenacin—Hypersensitivity—Methotrexate—colon cancer	0.00128	0.00164	CcSEcCtD
Darifenacin—Asthenia—Methotrexate—colon cancer	0.00125	0.0016	CcSEcCtD
Darifenacin—Pruritus—Methotrexate—colon cancer	0.00123	0.00158	CcSEcCtD
Darifenacin—Diarrhoea—Methotrexate—colon cancer	0.00119	0.00152	CcSEcCtD
Darifenacin—Dizziness—Methotrexate—colon cancer	0.00115	0.00147	CcSEcCtD
Darifenacin—Methadone—ABCB1—colon cancer	0.00112	0.129	CrCbGaD
Darifenacin—Vomiting—Methotrexate—colon cancer	0.00111	0.00142	CcSEcCtD
Darifenacin—Rash—Methotrexate—colon cancer	0.0011	0.0014	CcSEcCtD
Darifenacin—Dermatitis—Methotrexate—colon cancer	0.0011	0.0014	CcSEcCtD
Darifenacin—Headache—Methotrexate—colon cancer	0.00109	0.0014	CcSEcCtD
Darifenacin—Nausea—Methotrexate—colon cancer	0.00104	0.00132	CcSEcCtD
